These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30291488)

  • 41. Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.
    Anstey KJ; Ashby-Mitchell K; Peters R
    J Alzheimers Dis; 2017; 56(1):215-228. PubMed ID: 27911314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Orthostatic Hypotension: An Important Risk Factor for Clinical Progression to Mild Cognitive Impairment or Dementia. The Amsterdam Dementia Cohort.
    Kleipool EEF; Trappenburg MC; Rhodius-Meester HFM; Lemstra AW; van der Flier WM; Peters MJL; Muller M
    J Alzheimers Dis; 2019; 71(1):317-325. PubMed ID: 31381517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
    Vishnu VY; Modi M; Sharma S; Mohanty M; Goyal MK; Lal V; Khandelwal N; Mittal BR; Prabhakar S
    PLoS One; 2016; 11(11):e0166369. PubMed ID: 27861589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Shared effects of the clusterin gene on the default mode network among individuals at risk for Alzheimer's disease.
    Ye Q; Su F; Shu H; Gong L; Xie CM; Zhou H; Zhang ZJ; Bai F
    CNS Neurosci Ther; 2017 May; 23(5):395-404. PubMed ID: 28233427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease.
    Uddin MS; Kabir MT; Begum MM; Islam MS; Behl T; Ashraf GM
    Neurotox Res; 2021 Dec; 39(6):2108-2119. PubMed ID: 32820456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.
    Liu Y; Braidy N; Poljak A; Chan DKY; Sachdev P
    Ageing Res Rev; 2018 Nov; 47():41-48. PubMed ID: 29898422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clusterin mRNA and protein in Alzheimer's disease.
    Baig S; Palmer LE; Owen MJ; Williams J; Kehoe PG; Love S
    J Alzheimers Dis; 2012; 28(2):337-44. PubMed ID: 22232000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CLU rs11136000 promotes early cognitive decline in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pérez-González R; Pagonabarraga J; Kulisevsky J
    Mov Disord; 2020 Mar; 35(3):508-513. PubMed ID: 31930747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.
    Wood PL; Barnette BL; Kaye JA; Quinn JF; Woltjer RL
    Acta Neuropsychiatr; 2015 Oct; 27(5):270-8. PubMed ID: 25858158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycosylated clusterin species facilitate Aβ toxicity in human neurons.
    Foster EM; Fernandes M; Dangla-Valls A; Hublitz P; Pangalos M; Lovestone S; Ribe EM; Buckley NJ
    Sci Rep; 2022 Nov; 12(1):18639. PubMed ID: 36329114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COWAT Performance of Persons with Alzheimer Dementia, Vascular Dementia, and Parkinson Disease Dementia According to Stage of Cognitive Impairment.
    Lim KB; Kim J; Lee HJ; Yoo J; Kim HS; Kim C; Lee H
    PM R; 2019 Jul; 11(7):737-744. PubMed ID: 30746867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of plexin A4 as a novel clusterin receptor links two Alzheimer's disease risk genes.
    Kang SS; Kurti A; Wojtas A; Baker KE; Liu CC; Kanekiyo T; Deming Y; Cruchaga C; Estus S; Bu G; Fryer JD
    Hum Mol Genet; 2016 Aug; 25(16):3467-3475. PubMed ID: 27378688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
    Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
    Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clusterin CSF levels in differential diagnosis of neurodegenerative disorders.
    Přikrylová Vranová H; Hényková E; Mareš J; Kaiserová M; Menšíková K; Vaštík M; Hluštík P; Zapletalová J; Strnad M; Stejskal D; Kaňovský P
    J Neurol Sci; 2016 Feb; 361():117-21. PubMed ID: 26810527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.